Brief: Santen Pharmaceutical Says Agreement With Visiox Pharmaceuticals On Rights To Product Manufacturing, Commercialization, And Sales Of Omlonti
18/07/2023 22:10
July 18 (Reuters) - Santen Pharmaceutical Co Ltd
4536.T :
* SANTEN PHARMACEUTICAL CO LTD - AGREEMENT WITH VISIOX
PHARMACEUTICALS ON RIGHTS TO PRODUCT MANUFACTURING,
COMMERCIALIZATION, AND SALES OF OMLONTI
* SANTEN PHARMACEUTICAL CO LTD - ELIGIBLE TO RECEIVE SALES
MILESTONE PAYMENTS, AS WELL AS ROYALTIES ON NET U.S. SALES OF
OMLONTI UNDER AGREEMENT
Further company coverage: 4536.T
(Reuters.Briefs@thomsonreuters.com)